ArticleCell death & disease2022

Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.

Paulina Marona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.